Arog Pharmaceuticals, Inc.
17 clinical trials · Sponsor
◉ Watch Arog Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML (NCT03250338) | Arog Pharmaceuticals, Inc. | 2018-08-16 |
| Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML (NCT03258931) | Arog Pharmaceuticals, Inc. | 2018-08-15 |
| A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia (NCT03324243) | Arog Pharmaceuticals, Inc. | 2018-01-01 |
Track Arog Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.